🎉 M&A multiples are live!
Check it out!

Geron Valuation Multiples

Discover revenue and EBITDA valuation multiples for Geron and similar public comparables like Vivoryon Therapeutics, Julphar, and Benevolent AI.

Geron Overview

About Geron

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.


Founded

1990

HQ

United States of America
Employees

229

Website

geron.com

Financials

LTM Revenue $123M

LTM EBITDA n/a

EV

$556M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Geron Financials

Geron has a last 12-month revenue of $123M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Geron achieved revenue of $77.0M and an EBITDA of -$155M.

Geron expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Geron valuation multiples based on analyst estimates

Geron P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.2M $77.0M XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$175M -$155M XXX XXX XXX
EBITDA Margin -73748% -201% XXX XXX XXX
Net Profit -$142M -$184M XXX XXX XXX
Net Margin -59874% -239% XXX XXX XXX
Net Debt n/a $11.9M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Geron Stock Performance

As of April 15, 2025, Geron's stock price is $1.

Geron has current market cap of $841M, and EV of $556M.

See Geron trading valuation data

Geron Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$556M $841M XXX XXX XXX XXX $-0.22

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Geron Valuation Multiples

As of April 15, 2025, Geron has market cap of $841M and EV of $556M.

Geron's trades at 4.5x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Geron's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Geron and 10K+ public comps

Geron Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $556M XXX XXX XXX
EV/Revenue 7.2x XXX XXX XXX
EV/EBITDA -3.6x XXX XXX XXX
P/E -4.8x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -2.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Geron Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Geron Valuation Multiples

Geron's NTM/LTM revenue growth is 126%

Geron's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $1.1M for the same period.

Over next 12 months, Geron's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Geron's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Geron and other 10K+ public comps

Geron Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 32387% XXX XXX XXX XXX
EBITDA Margin -201% XXX XXX XXX XXX
EBITDA Growth -11% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -75% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $1.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 189% XXX XXX XXX XXX
R&D Expenses to Revenue 135% XXX XXX XXX XXX
Opex to Revenue 324% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Geron Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Geron M&A and Investment Activity

Geron acquired  XXX companies to date.

Last acquisition by Geron was  XXXXXXXX, XXXXX XXXXX XXXXXX . Geron acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Geron

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Geron

When was Geron founded? Geron was founded in 1990.
Where is Geron headquartered? Geron is headquartered in United States of America.
How many employees does Geron have? As of today, Geron has 229 employees.
Who is the CEO of Geron? Geron's CEO is Ms. Dawn Carter Bir.
Is Geron publicy listed? Yes, Geron is a public company listed on NAS.
What is the stock symbol of Geron? Geron trades under GERN ticker.
When did Geron go public? Geron went public in 1996.
Who are competitors of Geron? Similar companies to Geron include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Geron? Geron's current market cap is $841M
What is the current revenue of Geron? Geron's last 12-month revenue is $123M.
What is the current EV/Revenue multiple of Geron? Current revenue multiple of Geron is 4.5x.
What is the current revenue growth of Geron? Geron revenue growth between 2023 and 2024 was 32387%.
Is Geron profitable? Yes, Geron is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.